9-Fluoro-2,3-Dihydro-10-(4-Methyl-1-Piperazinyl)-7-Oxo-7H-Pyrido(1,2,3-de)-1,4-Benzothiazine-6-Carboxylic Acid 1-Oxide Monohydrochlo ride
CAS : 132843-25-5
Ref. 3D-FF103798
| Taille indéfinie | À demander |
Informations sur le produit
- 9-Fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzothiazine-6-carboxylic acid 1-oxide, monohydrochloride
- Rufloxacinsulfoxide
- 7H-Pyrido(1,2,3-de)-1,4-benzothiazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-, 1-oxide, monohydrochloride
- 9-fluoro-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]thiazino[2,3,4-ij]quinoline-6-carboxylic acid 1-oxide hydrochloride (1:1)
9-Fluoro-2,3-dihydro-10-(4-methyl-1-piperazinyl)-7-oxo-7H--pyrido(1,2,3-de)-1,4-benzothiazine--6--carboxylic acid 1 oxide monohydrochloride (9FDA) is a drug that has been used in pharmacokinetic studies in humans. It is administered as a single intravenous injection and has a half life of 12 hours. 9FDA is metabolized to 9FDAA and 9FDBA by the liver. The most abundant metabolites are found in urine after intravenous injections. The pharmacokinetics of this drug have been studied using high performance liquid chromatography with acetonitrile as the mobile phase. Constants were measured by injecting rhesus monkeys with 9FDA and measuring plasma concentrations over time using high performance liquid chromatography with an acetonitrile gradient
Propriétés chimiques
Question d’ordre technique sur : 3D-FF103798 9-Fluoro-2,3-Dihydro-10-(4-Methyl-1-Piperazinyl)-7-Oxo-7H-Pyrido(1,2,3-de)-1,4-Benzothiazine-6-Carboxylic Acid 1-Oxide Monohydrochlo ride
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
